FDA Inspection 1332732 — Genentech, Inc.
The FDA completed an inspection of Genentech, Inc. on Aug 4, 2026 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South San Francisco, CA (United States)
Additional details
Risk Evaluation and Mitigation Strategies (REMS)